Vtv Therapeutics Inc (VTVT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access VTVT Annual Balance Sheets →
The data below summarizes Vtv Therapeutics Inc's balance sheet position from Jun 30 2025 to Jun 30 2026, enabling a period-by-period comparison of financial strength.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent86.64
Cash & Short-term Investments86.00
Other Current Assets0.53
Prepaid Expense, Current AS0.42
Total Current Assets87.59
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset-
Total Assets87.59
Liabilities
Accounts Payable and Accrued Liabilities, Current LI6.99
Notes Payable, Current NO0.00
Other Liabilities, Current0.03
Total Current Liabilities7.02
Total Long-term Debt0.00
Other liabilities, Noncurrent1.94
Operating Lease Liability Current-
Contract With Customer Liability Noncurrent1.83
Total Liabilities8.96
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock394.21
Retained Earnings / Accumulated Deficit-315.61
Other Equity0.00
Common Stockholder's Equity78.63
Non-controlling interests & other0.00
Total Stockholder's Equity78.63
Liabilities & Stockholder's Equity87.59
4 historic quarters locked

Sign in to unlock the full Vtv Therapeutics Inc balance sheet history.

About Vtv Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001641489-26-000030

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.